경피 흡수 패치 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 패치 유형별, 접착제 유형별, 용도별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Transdermal Patches Market, valued at USD 6.85 Billion in 2024, is projected to experience a CAGR of 5.03% to reach USD 9.20 Billion by 2030. Transdermal patches represent medicated adhesive systems designed for systemic drug delivery through the skin, offering a non-invasive and consistent therapeutic dosage by bypassing hepatic first-pass metabolism. The market's growth is principally driven by the increasing global prevalence of chronic diseases requiring long-term medication management and a discernible patient preference for convenient, non-invasive drug administration over traditional oral or injectable routes.

Key Market Drivers

The escalating global burden of chronic diseases stands as a pivotal driver for the transdermal patches market, particularly for conditions necessitating continuous and often long-term medication management. Transdermal systems offer distinct advantages by enabling sustained drug release, which enhances patient adherence and therapeutic consistency over conventional oral or injectable routes. This non-invasive administration lessens the discomfort associated with frequent dosing and potential systemic side effects, improving the quality of life for individuals with persistent health issues.

Key Market Challenges

The inherent limitation of skin permeability poses a significant impediment to the growth of the Global Transdermal Patches Market. This physiological barrier fundamentally restricts the molecular size and physicochemical properties of active pharmaceutical ingredients that can be effectively delivered through the dermal route. Consequently, the range of drug candidates suitable for transdermal formulation is substantially narrowed, limiting the expansion of transdermal patches into numerous therapeutic areas. Large molecule biologics, for example, which represent a growing segment of pharmaceutical innovation, are generally incompatible with transdermal delivery due to their size.

Key Market Trends

Advancements in microneedle technology are fundamentally expanding transdermal drug delivery by overcoming the skin's barrier, enabling the administration of a wider range of therapeutic agents, including larger molecules. These patches create microscopic channels in the stratum corneum for efficient drug permeation with minimal invasiveness and reduced discomfort, broadening transdermal applications.

Key Market Players

• AbbVie, Inc.
• AdhexPharma SAS
• Agile Therapeutics, Inc.
• Boehringer Ingelheim International GmbH
• Corium, Inc.
• GlaxoSmithKline PLC
• Johnson & Johnson Services, Inc.
• Novartis AG
• Hamamatsu Pharma Research, Inc.
• Endo, Inc.

Report Scope:

In this report, the Global Transdermal Patches Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transdermal Patches Market, By Patch Type:

• Drug-In-Adhesive
• Matrix Patches
• Reservoir Membrane Patches
• Microneedle Patches
• Vapour Patches

Transdermal Patches Market, By Adhesive Type:

• Acrylic
• Silicone
• Hydrogel
• Other

Transdermal Patches Market, By Application:

• Pain Management
• Hormonal Application
• Central Nervous System Disorders
• Cardiovascular Diseases
• Smoking Cessation
• Other

Transdermal Patches Market, By End-User:

• Homecare Settings
• Hospitals & Clinics

Transdermal Patches Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transdermal Patches Market.

Available Customizations:

Global Transdermal Patches Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transdermal Patches Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Patch Type (Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Vapour Patches)
  • 5.2.2. By Adhesive Type (Acrylic, Silicone, Hydrogel, Other)
  • 5.2.3. By Application (Pain Management, Hormonal Application, Central Nervous System Disorders, Cardiovascular Diseases, Smoking Cessation, Other)
  • 5.2.4. By End-User (Homecare Settings, Hospitals & Clinics)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Transdermal Patches Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Patch Type
  • 6.2.2. By Adhesive Type
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Transdermal Patches Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Patch Type
      • 6.3.1.2.2. By Adhesive Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Transdermal Patches Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Patch Type
      • 6.3.2.2.2. By Adhesive Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Transdermal Patches Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Patch Type
      • 6.3.3.2.2. By Adhesive Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User

7. Europe Transdermal Patches Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Patch Type
  • 7.2.2. By Adhesive Type
  • 7.2.3. By Application
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Transdermal Patches Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Patch Type
      • 7.3.1.2.2. By Adhesive Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Transdermal Patches Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Patch Type
      • 7.3.2.2.2. By Adhesive Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Transdermal Patches Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Patch Type
      • 7.3.3.2.2. By Adhesive Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Transdermal Patches Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Patch Type
      • 7.3.4.2.2. By Adhesive Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Transdermal Patches Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Patch Type
      • 7.3.5.2.2. By Adhesive Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia Pacific Transdermal Patches Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Patch Type
  • 8.2.2. By Adhesive Type
  • 8.2.3. By Application
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Transdermal Patches Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Patch Type
      • 8.3.1.2.2. By Adhesive Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Transdermal Patches Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Patch Type
      • 8.3.2.2.2. By Adhesive Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Transdermal Patches Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Patch Type
      • 8.3.3.2.2. By Adhesive Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Transdermal Patches Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Patch Type
      • 8.3.4.2.2. By Adhesive Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Transdermal Patches Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Patch Type
      • 8.3.5.2.2. By Adhesive Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Transdermal Patches Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Patch Type
  • 9.2.2. By Adhesive Type
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Transdermal Patches Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Patch Type
      • 9.3.1.2.2. By Adhesive Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Transdermal Patches Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Patch Type
      • 9.3.2.2.2. By Adhesive Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Transdermal Patches Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Patch Type
      • 9.3.3.2.2. By Adhesive Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User

10. South America Transdermal Patches Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Patch Type
  • 10.2.2. By Adhesive Type
  • 10.2.3. By Application
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Transdermal Patches Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Patch Type
      • 10.3.1.2.2. By Adhesive Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Transdermal Patches Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Patch Type
      • 10.3.2.2.2. By Adhesive Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Transdermal Patches Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Patch Type
      • 10.3.3.2.2. By Adhesive Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Transdermal Patches Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. AbbVie, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. AdhexPharma SAS
• 15.3. Agile Therapeutics, Inc.
• 15.4. Boehringer Ingelheim International GmbH
• 15.5. Corium, Inc.
• 15.6. GlaxoSmithKline PLC
• 15.7. Johnson & Johnson Services, Inc.
• 15.8. Novartis AG
• 15.9. Hamamatsu Pharma Research, Inc.
• 15.10. Endo, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer